Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis - Wikidata - wikimedia - TriplyDB

Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis

Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis

http://www.wikidata.org/entity/Q42025909

about

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20 Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells Increased internalization of complement inhibitor CD59 may contribute to endothelial inflammation in obstructive sleep apnea.Mesenchymal stem cells are injured by complement after their contact with serum Statins and the vascular endothelial inflammatory response Peripheral tolerance can be modified by altering KLF2-regulated Treg migration Evaluation of the Anti-inflammatory Effects of Atorvastatin on Patients with Rheumatoid Arthritis: A Randomized Clinical Trial The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in rheumatologic disorders: a comprehensive review.Cytoprotective signaling and gene expression in endothelial cells and macrophages-lessons for atherosclerosis.Geranylgeranylacetone, a non-toxic inducer of heat shock protein, induces cell death in fibroblast-like synoviocytes from patients with rheumatoid arthritis.CD59 polymorphisms are associated with gene expression and different sexual susceptibility to pemphigus foliaceus.

P2860

Q28472420-B7D7FE64-DF57-40B0-BAF2-D4521D41AC58 Q33407861-7CDE7860-9F4D-4CC7-9CAE-125C01089984 Q33838270-BF2C63E1-1F33-4189-A5C8-DEFA6C0201E1 Q36352514-4578AED6-4892-4205-A266-3A34C78C0192 Q36695979-E6D1370A-88ED-4E7A-94C3-4D7862324C7E Q37181861-F71EB34F-73AD-4E03-9B54-3B119FDA3AFE Q37316891-E5DF0963-6F7C-4DDA-8C8F-5F0ABF538D88 Q37909189-E2D860EA-A5F3-47D9-A2A0-BB49DF6A9061 Q38057357-E472997D-0773-4B64-AB1F-B5DA84773787 Q45969381-E8A6B06C-A67F-4A2A-9435-5191BE17BED6 Q52642180-197D051B-8975-46A9-B990-79E16E81C90B

P2860

Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis

http://www.wikidata.org/entity/Q42025909

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Statin-induced expression of C ...... tatins in rheumatoid arthritis

@en

Statin-induced expression of C ...... tatins in rheumatoid arthritis

@nl

type

label

Statin-induced expression of C ...... tatins in rheumatoid arthritis

@en

Statin-induced expression of C ...... tatins in rheumatoid arthritis

@nl

prefLabel

Statin-induced expression of C ...... tatins in rheumatoid arthritis

@en

Statin-induced expression of C ...... tatins in rheumatoid arthritis

@nl

P1433

Q42025909-CA6D2413-8001-44FF-8C97-AF1D85D26809

P1476

Q42025909-6F4B3C9C-69EF-487D-AA06-AFC014327061

P2093

Q42025909-3D658CDF-D787-4DB0-B1E5-0D265C63ADAF

Q42025909-456BA0B2-56D3-49AC-AFED-E8466FC5FEDA

Q42025909-48C0BD71-8D13-44E8-992E-5ED2D75C7081

Q42025909-82536B97-F979-4836-852F-3671DC70AA3A

Q42025909-AE88BBDA-D5C3-4CA7-A71A-84D2BB23907E

Q42025909-CE0FE7CB-903A-4CC7-9434-8115B6299685

Q42025909-CE2841ED-89E0-4270-8E29-F41A1162C526

P2860

Q42025909-105D7633-9A9B-44CF-8115-25FAE2B24038

Q42025909-121B6BC9-C99F-4C4A-9EEF-D61D855AFAD6

Q42025909-1513B6C4-9086-4FDA-ABA6-977A464716FB

Q42025909-1DFA19A2-4DB8-42B8-86C3-3238B08AEB98

Q42025909-2AADB3F1-C18C-4F80-B43C-B16F8418D2A3

Q42025909-325D553E-0A42-4441-9F08-BAA280C2534A

Q42025909-3C4675F1-F70F-4450-A4D7-CE088BC25A6D

Q42025909-45BFE28B-A505-4EBF-9F14-E7AA7BF0B602

Q42025909-48086D40-2693-42BC-982C-77CA036B16AB

Q42025909-4E2B4E29-4846-4552-B913-D2B7F043A2D0

P2888

Q42025909-4C275BA0-8ADA-4D27-AEB0-806ACA0F60B2

P304

Q42025909-ED766AD1-5866-41F7-B220-77E91F288FEC

P31

Q42025909-B6010820-4B19-445F-854F-F8C09901479D

P356

Q42025909-02E0DAE9-1318-4284-B76F-A808A34979D2

P433

Q42025909-FF5ECCF0-8B2C-4624-AC87-66D46B6DE4F2

P478

Q42025909-5181E035-7D7E-49E6-A78D-830D1DF32432

P50

Q42025909-5CC7F490-4ED1-4EB8-A446-FC571EDC9A3C

P577

Q42025909-1541C2ED-CA4E-467D-879A-7D6A0A421F6A

P5875

Q42025909-447E0243-2AF6-4462-8559-786B6F00A87D

P6179

Q42025909-01AA158A-C2D6-4FCA-86CF-05ABE1EECBDC

P698

Q42025909-2CECC6CE-2161-49EF-BE7B-3EF089B672EC

P921

Q42025909-3E6A0D00-F430-43B4-9D2D-8EE186C577B7

Q42025909-C01C5E79-B6E9-4EB5-B8EA-5E6E3AC8D806

Q42025909-EC8B1997-079A-4B62-9F47-1DE9FE88668C

P932

Q42025909-844B0C1F-323E-44E3-92A8-90DFA68DD2DA

P356

P1433

Arthritis Research and Therapy

P1476

Statin-induced expression of C ...... tatins in rheumatoid arthritis

@en

P2093

Anne R Kinderlerer

http://www.w3.org/2001/XMLSchema#string

Dorian O Haskard

http://www.w3.org/2001/XMLSchema#string

Elaine A Lidington

http://www.w3.org/2001/XMLSchema#string

Justin C Mason

http://www.w3.org/2001/XMLSchema#string

Michael Johns

http://www.w3.org/2001/XMLSchema#string

Rivka Steinberg

http://www.w3.org/2001/XMLSchema#string

Sarah K Harten

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL

Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis

Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane.

Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease.

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.

Control of the complement system.

Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.

Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis.

Hypoxia and angiogenesis in rheumatoid arthritis.

HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells.

P2888

P304

R130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR2019

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Patrick H Maxwell

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6925627

http://www.w3.org/2001/XMLSchema#string

P6179

1050304436

http://www.w3.org/2001/XMLSchema#string

P698

16859540

http://www.w3.org/2001/XMLSchema#string

P921

P932

1779384

http://www.w3.org/2001/XMLSchema#string